| 摘要 |
The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof, wherein X<SUB>1</SUB>, X<SUB>2</SUB>, R<SUB>1</SUB> R<SUB>2</SUB>, R<SUB>3</SUB> and R<SUB>4</SUB> are as defined herein, and their methods of preparation and use as ADP inhibitors.
|
| 申请人 |
JANSSEN PHARMACEUTICA, N.V.;ZHANG, HAN-CHENG;MARYANOFF, BRUCE, E.;YE, HONG;CHEN, CAILIN |
发明人 |
ZHANG, HAN-CHENG;MARYANOFF, BRUCE, E.;YE, HONG;CHEN, CAILIN |
